Life sciences organizations now manage all quality control data and processes in one solution for greater efficiency and speed PLEASANTON, Calif., Aug. 22, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced increasing momentum for Veeva Vault LIMS, a modern cloud solution that simplifies end-to-end quality control (QC) business processes. Vault LIMS is unified with Veeva Vault Quality, enabling customers to share data and content across quality applications for more informed batch release decis ...

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though? Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Veeva Systems (VEEV) . Veeva currently has an average brokerage ...

In the latest trading session, Veeva Systems (VEEV) closed at $194.28, marking a +0.92% move from the previous day. The stock fell short of the S&P 500, which registered a gain of 0.97% for the day. Meanwhile, the Dow experienced a rise of 0.58%, and the technology-dominated Nasdaq saw an increase of 1.39%. Heading into today, shares of the provider of cloud-based software services for the life sciences industry had gained 5.05% over the past month, outpacing the Computer and Technology sector's loss of 5.3 ...

AbbVie, Astellas, Eikon, Merck, Moderna, Roche, and more share new ideas to advance drug development PLEASANTON, Calif., Aug. 13, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that industry leaders from AbbVie, Astellas, Eikon Therapeutics, Merck & Co., Moderna, and Roche will keynote at the upcoming 2024 Veeva R&D and Quality Summit in Boston on Sept. 9-10. Professionals across life sciences will come together to discuss how connected systems across clinical, regulatory, safety, and quali ...

PLEASANTON, Calif., Aug. 7, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) will announce financial results for its second quarter, which ended July 31, 2024, after market close on August 28, 2024. Veeva will host a conference call and webcast that day at 2:00 p.m. PT (5:00 p.m. ET) to discuss its financial results. Veeva will post prepared remarks to its investor relations website at https://ir.veeva.com approximately at 1:05 p.m. PT (4:05 p.m. ET). A webcast replay will be available on the website followi ...

Veeva Systems (VEEV) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares of this provider of cloud-based software services for the life sciences industry have returned +5.9% over the past month versus the Zacks S&P 500 composite's +1.1% change. The Zacks Internet - Software industry, to which Veeva belongs, has lost 6.4% over this period. Now the key question is: Where could ...

PLEASANTON, Calif., July 25, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today revealed that targeted pre-launch scientific outreach maximizes medical affairs teams' impact on treatment adoption in the latest Veeva Pulse Field Trends Report. The analysis shows biopharmas investing in pre-launch scientific activities and prioritizing congresses gain 40% faster treatment adoption than those that invested less. Earlycareer experts are also more open to digital engagement and four times more likely to start ...

BARCELONA, Spain, July 25, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Neuraxpharm will use Veeva Vault QualityDocs and Veeva Vault Training to advance its quality operations. Veeva quality applications will help Neuraxpharm achieve greater oversight and inspection readiness, while improving collaboration across its network of over 100 contract development and manufacturing organizations (CDMOs). Neuraxpharm is a pharmaceutical leader in disorders affecting the central nervous syste ...

Boston Scientific, carrying a Zacks Rank of 2 at present, has an estimated long-term growth rate of 12.5%. BSX's earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 7.5%. Boston Scientific's shares have rallied 46.3% against the industry's 1.8% decline in the past year. Veeva Systems Inc. (VEEV) recently announced that it is partnering with Vita Global Sciences. The partnership aims to modernize the latter's clinical data management processes and improve colla ...

In the latest market close, Veeva Systems (VEEV) reached $180.43, with a -0.82% movement compared to the previous day. This change lagged the S&P 500's 0.78% loss on the day. On the other hand, the Dow registered a loss of 1.29%, and the technology-centric Nasdaq decreased by 0.7%. The investment community will be paying close attention to the earnings performance of Veeva Systems in its upcoming release. The company is predicted to post an EPS of $1.53, indicating a 26.45% growth compared to the equivalent ...